Cybersecurity and You—Manage Cyber Risks at Home, at Work, and On the Go

Corporate & Institutional
3XbyAD-CJsCsTIaB_9TMNj-b

Protecting your information is one of our top priorities, but we can’t always be where you are. It’s essential that you understand how your technology, and the way that you use it, could be putting you at an increased risk for a cyberattack. Wilmington Trust and M&T have partnered to deliver a digital, interactive experience that allows you to take a new perspective on the technology in your home, at your office, and while you travel.

Read More...


Episode 7: The Cure for What Ails Us Part II—A Dose of Medicine: Evaluating the State of Play from Therapies to Vaccines

Tony Roth |
Capital Considerations with Tony Roth
45455_WWW_Episode_7_NC.jpg

April 20—Chief Investment Officer Tony Roth speaks with Ofer Levy, MD, PhD, physician-scientist in pediatric infectious diseases, Director of the Precision Vaccines Program at Boston Children’s Hospital, and Professor at Harvard Medical School. Dr. Levy discusses the race to develop therapeutics, including plasma therapies, and when we can expect a viable vaccine.

Listen...


Episode 6: The Cure for What Ails Us Part I—What Makes This Virus Different From All Other Viruses?

Tony Roth |
Capital Considerations with Tony Roth
45455_WWW_Episode_6_NC.jpg

April 20—University of Pennsylvania microbiologist Susan Weiss, PhD, co-director of the Center for Research on Coronaviruses and Other Emerging Pathogens, joins Chief Investment Officer Tony Roth to discuss the origins of the coronavirus, a field Dr. Weiss has researched for more than four decades. Listen as Dr. Weiss walks us through the biology and epidemiology of COVID-19.

Listen...